Why No Uproar Over Ovarian Cancer Screening Guidelines?

In September the United States Preventive Services Taskforce, a panel of medical experts, concluded that tests to screen for ovarian cancer do more harm than good. As a result, insurers will not be required by federal law to pay for such tests.
And the announcement was met with near silence.
Why was this recommendation greeted with such malaise when the same panel’s… (Read more and view comments at Forbes)